FDA To Require Adverse Event E-Submissions For “AERS II” Launch
Executive Summary
FDA will start requiring the electronic submission of adverse event reports for implementation of its second-generation Adverse Event Reporting System database in 2007-2008
You may also be interested in...
FDA Increasing Use Of Data Mining To Detect Early Safety Signals
FDA is making increased use of data mining software to identify early drug safety signals in its adverse event database, Office of Pharmacoepidemiology & Statistical Science Director Paul Seligman said
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011